相似文献
1
Mycological and clinical evaluation of griseofulvin for chronic onychomycosis.
Br Med J. 1967 Aug 19;3(5563):464-8. doi: 10.1136/bmj.3.5563.464.
2
Pharmacoeconomic analysis of oral antifungal therapies used to treat dermatophyte onychomycosis of the toenails. A US analysis.
Pharmacoeconomics. 1998 Feb;13(2):243-56. doi: 10.2165/00019053-199813020-00007.
3
Efficacy of itraconazole, terbinafine, fluconazole, griseofulvin and ketoconazole in the treatment of Scopulariopsis brevicaulis causing onychomycosis of the toes.
Dermatology. 2001;202(3):235-8. doi: 10.1159/000051643.
4
A questionnaire study on the management of onychomycosis: a Canadian perspective.
Int J Dermatol. 1998 Jun;37(6):457-60. doi: 10.1046/j.1365-4362.1998.00409.x.
5
A cost/efficacy analysis of oral antifungals indicated for the treatment of onychomycosis: griseofulvin, itraconazole, and terbinafine.
Am J Manag Care. 1997 Mar;3(3):443-50.
6
Treatment of toenail onychomycosis. A randomized, double-blind study with terbinafine and griseofulvin. LAGOS II Study Group.
Arch Dermatol. 1995 Aug;131(8):919-22. doi: 10.1001/archderm.131.8.919.
7
[Clinical and mycological studies of griseofulvin treated onychomycoses].
Mycopathol Mycol Appl. 1965 Apr 14;25(3):351-60. doi: 10.1007/BF02049921.
8
Cumulative meta-analysis of systemic antifungal agents for the treatment of onychomycosis.
Br J Dermatol. 2004 Mar;150(3):537-44. doi: 10.1046/j.1365-2133.2003.05728.x.
9
Treatment of onychomycosis: a randomized, double-blind comparison study with topical bifonazole-urea ointment alone and in combination with short-duration oral griseofulvin.
Int J Dermatol. 1997 Jan;36(1):67-9. doi: 10.1046/j.1365-4362.1997.00024.x.
10
Pharmacoeconomic analysis of ciclopirox nail lacquer solution 8% and the new oral antifungal agents used to treat dermatophyte toe onychomycosis in the United States.
J Am Acad Dermatol. 2000 Oct;43(4 Suppl):S81-95. doi: 10.1067/mjd.2000.109069.
引用本文的文献
1
Antifungal Selection for the Treatment of Onychomycosis: Patient Considerations and Outcomes.
Infect Drug Resist. 2024 Mar 4;17:819-843. doi: 10.2147/IDR.S431526. eCollection 2024.
2
Pharmacokinetics of antifungal agents in onychomycoses.
Clin Pharmacokinet. 2001;40(6):441-72. doi: 10.2165/00003088-200140060-00005.
3
Onychomycosis in the elderly.
Drugs Aging. 2000 Jun;16(6):397-407. doi: 10.2165/00002512-200016060-00002.
4
A risk-benefit assessment of the newer oral antifungal agents used to treat onychomycosis.
Drug Saf. 2000 Jan;22(1):33-52. doi: 10.2165/00002018-200022010-00004.
5
Pharmacoeconomic analysis of oral antifungal therapies used to treat dermatophyte onychomycosis of the toenails. A US analysis.
Pharmacoeconomics. 1998 Feb;13(2):243-56. doi: 10.2165/00019053-199813020-00007.
6
Clinical and economic factors in the treatment of onychomycosis.
Pharmacoeconomics. 1996 Apr;9(4):307-20. doi: 10.2165/00019053-199609040-00004.
7
Terbinafine. A pharmacoeconomic evaluation of its use in superficial fungal infections.
Pharmacoeconomics. 1995 Sep;8(3):253-69. doi: 10.2165/00019053-199508030-00008.
8
Onychomycosis. Going for cure.
Can Fam Physician. 1997 Feb;43:299-305.
9
Onychomycosis. New therapies for an old disease.
West J Med. 1996 Dec;165(6):349-51.
10
Itraconazole. A reappraisal of its pharmacological properties and therapeutic use in the management of superficial fungal infections.
Drugs. 1996 Apr;51(4):585-620. doi: 10.2165/00003495-199651040-00006.
本文引用的文献
1
GRISEOFULVIN ADMINISTRATION AND PORPHYRIN METABOLISM. A SURVEY.
Lancet. 1963 Aug 17;2(7303):318-22. doi: 10.1016/s0140-6736(63)92989-1.
2
Disturbance of porphyrin metabolism caused by griseofulvin in mice.
Br J Dermatol. 1963 Mar;75:91-104. doi: 10.1111/j.1365-2133.1963.tb13945.x.
3
Griseofulvin for the systemic treatment of dermatomycoses.
J Am Med Assoc. 1959 Dec 19;171:2168-73. doi: 10.1001/jama.1959.03010340012003.
4
Storage and retrieval of biological information.
Nature. 1961 Jul 1;191:12-4. doi: 10.1038/191012a0.
5
Presence of griseofulvin in hair of guinea pigs after oral administration.
Nature. 1959 Jan 24;183(4656):256-7. doi: 10.1038/183256a0.
6
Oral treatment of ringworm with griseofulvin.
Lancet. 1958 Dec 6;2(7058):1212-3. doi: 10.1016/s0140-6736(58)92363-8.
7
Some cytological effects of griseofulvin.
Nature. 1958 Nov 8;182(4645):1320-1. doi: 10.1038/1821320a0.
8
Experimental ringworm in guinea pigs: oral treatment with griseofulvin.
Nature. 1958 Aug 16;182(4633):476-7. doi: 10.1038/182476a0.
Zotero 插件